BGASX
Price
$16.94
Change
-$0.34 (-1.97%)
Updated
Feb 21 closing price
Net Assets
799.35M
RNPHX
Price
$64.29
Change
-$0.79 (-1.21%)
Updated
Feb 21 closing price
Net Assets
147.51B
Ad is loading...

BGASX vs RNPHX

Header iconBGASX vs RNPHX Comparison
Open Charts BGASX vs RNPHXBanner chart's image
Baillie Gifford Global Alpha Equities I
Price$16.94
Change-$0.34 (-1.97%)
VolumeN/A
Net Assets799.35M
American Funds New Perspective R5E
Price$64.29
Change-$0.79 (-1.21%)
VolumeN/A
Net Assets147.51B
BGASX vs RNPHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BGASX vs. RNPHX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BGASX is a Hold and RNPHX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RNPHX has more cash in the bank: 148B vs. BGASX (799M). BGASX (1.01) and RNPHX (1.00) have matching dividends . BGASX was incepted earlier than RNPHX: BGASX (8 years) vs RNPHX (9 years). BGASX is a more actively managed with annual turnover of: 19.00 vs. RNPHX (17.00). BGASX has a lower initial minimum investment than RNPHX: BGASX (0) vs RNPHX (250). RNPHX annual gain was more profitable for investors over the last year : 10.58 vs. BGASX (2.02). RNPHX return over 5 years is better than : 34.72 vs. BGASX (3.01).
BGASXRNPHXBGASX / RNPHX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years9 years-
Gain YTD5.2834.639114%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets799M148B1%
Annual Yield % from dividends1.011.00102%
Returns for 1 year2.0210.5819%
Returns for 3 years4.8914.8433%
Returns for 5 years3.0134.729%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GOGO7.960.08
+1.02%
Gogo
PUK17.99-0.18
-0.99%
Prudential PLC
ABTS0.41-0.01
-2.14%
Abits Group
RARE42.59-1.89
-4.25%
Ultragenyx Pharmaceutical
SMID34.74-2.37
-6.39%
Smith-Midland Corp